news
10-30-2023, 04:41 PM
FDA approves Junshi, Coherus’ PD-1 toripalimab for nasopharyngeal carcinoma (https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZW5kcHRzLmNvbS9mZGEtYXBwcm92ZXMtan Vuc2hpLWNvaGVydXMtcGQtMS10b3JpcGFsaW1hYi1mb3ItbmFz b3BoYXJ5bmdlYWwtY2FyY2lub21hL9IBAA?oc=5) Endpoints News
Coherus rejects 'heavily discounted' pricing on Loqtorzi, the first China-made PD-1 drug to win FDA nod (https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm 1hL2ZpcnN0LWNoaW5hLW1hZGUtcGQtMS1hcHByb3ZlZC1mZGEt Y29oZXJ1cy1yZW5vdW5jZXMtaGVhdmlseS1kaXNjb3VudGVkLX ByaWNpbmctanVuc2hpc9IBAA?oc=5) FiercePharma
FDA Approves Loqtorz Regimens for Advanced Nasopharyngeal Carcinoma (https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmN1cmV0b2RheS5jb20vdmlldy9mZG EtYXBwcm92ZXMtbG9xdG9yei1yZWdpbWVucy1mb3ItYWR2YW5j ZWQtbmFzb3BoYXJ5bmdlYWwtY2FyY2lub21h0gEA?oc=5) Curetoday.com
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) (https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jb2 hlcnVzLWp1bnNoaS1iaW9zY2llbmNlcy1hbm5vdW5jZS1mZGEt MTkwNzAwNDE5Lmh0bWzSAV1odHRwczovL2ZpbmFuY2UueWFob2 8uY29tL2FtcGh0bWwvbmV3cy9jb2hlcnVzLWp1bnNoaS1iaW9z Y2llbmNlcy1hbm5vdW5jZS1mZGEtMTkwNzAwNDE5Lmh0bWw?oc =5) Yahoo Finance
Peninsula drug maker Coherus wins FDA cancer drug approval, extends one lease, exits other space - San Francisco Business Times (https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcm FuY2lzY28vbmV3cy8yMDIzLzEwLzI3L2NhbmNlci1jb2hlcnVz LWJpb3NjaWVuY2VzLWxlYXNlLWxvcXRvcnppLWp1bnNoaS5odG 1s0gEA?oc=5) The Business Journals
View Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2kzbV lmS0NSRWRwbFhQc1V0N21pZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5)
More... (https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZW5kcHRzLmNvbS9mZGEtYXBwcm92ZXMtan Vuc2hpLWNvaGVydXMtcGQtMS10b3JpcGFsaW1hYi1mb3ItbmFz b3BoYXJ5bmdlYWwtY2FyY2lub21hL9IBAA?oc=5)
Coherus rejects 'heavily discounted' pricing on Loqtorzi, the first China-made PD-1 drug to win FDA nod (https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm 1hL2ZpcnN0LWNoaW5hLW1hZGUtcGQtMS1hcHByb3ZlZC1mZGEt Y29oZXJ1cy1yZW5vdW5jZXMtaGVhdmlseS1kaXNjb3VudGVkLX ByaWNpbmctanVuc2hpc9IBAA?oc=5) FiercePharma
FDA Approves Loqtorz Regimens for Advanced Nasopharyngeal Carcinoma (https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmN1cmV0b2RheS5jb20vdmlldy9mZG EtYXBwcm92ZXMtbG9xdG9yei1yZWdpbWVucy1mb3ItYWR2YW5j ZWQtbmFzb3BoYXJ5bmdlYWwtY2FyY2lub21h0gEA?oc=5) Curetoday.com
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi) in All Lines of Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) (https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9jb2 hlcnVzLWp1bnNoaS1iaW9zY2llbmNlcy1hbm5vdW5jZS1mZGEt MTkwNzAwNDE5Lmh0bWzSAV1odHRwczovL2ZpbmFuY2UueWFob2 8uY29tL2FtcGh0bWwvbmV3cy9jb2hlcnVzLWp1bnNoaS1iaW9z Y2llbmNlcy1hbm5vdW5jZS1mZGEtMTkwNzAwNDE5Lmh0bWw?oc =5) Yahoo Finance
Peninsula drug maker Coherus wins FDA cancer drug approval, extends one lease, exits other space - San Francisco Business Times (https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcm FuY2lzY28vbmV3cy8yMDIzLzEwLzI3L2NhbmNlci1jb2hlcnVz LWJpb3NjaWVuY2VzLWxlYXNlLWxvcXRvcnppLWp1bnNoaS5odG 1s0gEA?oc=5) The Business Journals
View Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2kzbV lmS0NSRWRwbFhQc1V0N21pZ0FQAQ?hl=en-US&gl=US&ceid=US:en&oc=5)
More... (https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZW5kcHRzLmNvbS9mZGEtYXBwcm92ZXMtan Vuc2hpLWNvaGVydXMtcGQtMS10b3JpcGFsaW1hYi1mb3ItbmFz b3BoYXJ5bmdlYWwtY2FyY2lub21hL9IBAA?oc=5)